Smoking Cessation Clinical Trials
59 studies are recruiting for smoking cessation in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 3
-
Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity
This study will randomize 64 non-treatment seeking individuals who smoke cigarettes daily in a double-blind, placebo-controlled laboratory study testing the effects of cytisinicline on the neural substrates of cigarette cue reactivity.
- Stage
- Phase 2
- Ages
- 18 to 65
- Site
- University of California Los Angeles, Los Angeles, California
- Run by
- University of California, Los Angeles
-
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
The purpose of this study is to obtain biologic materials from the blood, airways and/or urine of normal individuals and individuals with lung disease. The normal are used to establish a set of normal ranges for various parameters. These provide control information when compared to individuals with…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine, New York, New York
- Run by
- Weill Medical College of Cornell University
-
Technology Assisted Motivational Interviewing
Building on our successful pilot work to develop a Motivational Interviewing (MI)-capable chatbot and cessation coach, the investigators propose to address the problems of intrinsic motivation and social barriers to smoking cessation by evaluating a highly scalable and easily accessible digital-coa…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- San Francisco General Hospital, San Francisco, California
- Locations
- 2 in total
- Run by
- University of California, San Francisco
-
Wellness Intervention for Smoking and HIV
The investigators propose to use a parallel group, randomized controlled trial to test the efficacy of a 13-week personalized approach to reducing smoking intervention versus a second approach using a different health intervention on smoking cessation, healthy sleep metrics, and biomarkers of cardi…
- Stage
- Not phased
- Ages
- 18 to 75
- Site
- Banner University Medical Center Phoenix, Phoenix, Arizona
- Locations
- 2 in total
- Run by
- University of Arizona
-
Healing Within: Mindfulness Smoking Cessation Intervention
Using a highly participatory approach, this study will assess the feasibility, acceptability, and satisfaction with a culturally tailored, trauma-informed smoking cessation intervention for Northern Plains Tribal women who have experienced intimate partner violence. If successful, other American In…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Black Hills Center for American Indian Health, Rapid City, South Dakota
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
-
V+PSF-M for Tobacco Cessation in HIV Care in India
The goal of this research study is to test an intervention to help quit tobacco use in participants with Human Immunodeficiency Virus (HIV). The study interventions used in this research study are: * Positively Smoke Free - Mobile (PSF-M) (mobile behavioral program) * Varenicline (or Chantix, apova…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- University of Colorado, Aurora, Colorado
- Locations
- 2 in total
- Run by
- University of Colorado, Denver
-
Testing the mHealth App Intervention for Nondaily Smokers "SiS4"
The goal of this project is to test if a new behavioral treatment for people who smoke nondaily and wish to quit works. The new treatment is a smartphone app that engages users in positive psychology exercises and gives them tested tools for quitting smoking. The positive psychology exercises help …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Run by
- Massachusetts General Hospital
-
New Strategies to Enhance Smoking Cessation
The study goal is to get feedback on ways researchers can communicate complex research findings on smoking cessation to better inform patients' decisions to use medication and/or quit smoking. This will help researchers and clinicians to provide effective, easy-to-implement treatments designed to a…
- Stage
- Not phased
- Ages
- 18 to 75
- Site
- University of Chicago, Chicago, Illinois
- Run by
- University of Chicago
-
Remote Smoking Cessation in Hospitalized Cardiac Patients
The investigators are proposing to examine new strategies for helping patients hospitalized for an acute coronary event adhere to recommendations to quit smoking. The investigators are interested to see whether offering financial incentives for smoking cessation, combined with medications to amelio…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Vermont Medical Center, Burlington, Vermont
- Run by
- University of Vermont Medical Center
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.